| Authors: |
Lodise TP; Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York, USA., Das AF; Biostatistics, UTILITY therapeutics, London, United Kingdom.; AD Stat Consulting, Guerneville, California, USA., Frimodt-Møller N; Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark., Gupta K; Department of Medicine, VA Boston and Boston University School of Medicine, Boston, Massachusetts, USA., Rodvold KA; College of Pharmacy and College of Medicine, University of Illinois-Chicago, Chicago, Illinois, USA., Santerre Henriksen A; Clinical Development, Maxel Consulting ApS, Jyllinge, Denmark.; Clinical Development, UTILITY therapeutics, London, United Kingdom., Sommer MOA; Clinical Development, UTILITY therapeutics, London, United Kingdom.; DTU Biosustain, Technical University of Denmark, Lyngby, Denmark., Wagenlehner F; Department of Urology, Pediatric Urology and Andrology, Justus Liebig University Giessen, Giessen, Germany., Kaye KS; Division of Allergy, Immunology and Infectious Diseases, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA. |
